XENE
USDXenon Pharmaceuticals Inc. Common Shares
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$39.740
Haut
$40.450
Bas
$37.625
Volume
0.18M
Fondamentaux de l'Entreprise
Capitalisation Boursière
3.0B
Industrie
Biotechnologie
Pays
Canada
Statistiques de Trading
Volume Moyen
0.79M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.
Xenon to Report Q3 2025 Financial Results on November 3, 2025
VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.